Join Biotts at the RESI Conference in Boston!

Biotts is excited to announce our participation in the upcoming RESI Conference in Boston! This event is a prime opportunity to engage with early-stage investors and biotech innovators. We encourage you to explore potential collaborations and learn about our groundbreaking transdermal drug delivery solutions. Our CEO, Jan Henk Hendriks, will be available for meetings throughout […]

Read more

MEDIA: Biotts’ Insulin Patch – A Game-Changer for Diabetes Patients

We are pleased to share the latest update on a significant breakthrough in diabetes treatment from our team at Biotts. Our innovative stick-on patch, designed to regulate blood sugar levels more effectively and than traditional insulin injections, continues to make headlines. Key Highlights: Renowned figures like tennis star Alexander Zverev and Olympic legend Sir Steve […]

Read more

MTC-I Transdermal Insulin: New In-Vivo Results

We are pleased to share the latest in-vivo results from our ongoing research together with Bioton into our innovative transdermal insulin delivery system. Our MTC-Y technology continues to demonstrate encouraging performance when compared to traditional subcutaneous insulin administration. Study Design Our comparative study utilized: We employed male Sprague Dawley rats as the animal model, measuring […]

Read more

Biotts’ presentation AT SUSHI TECH TOKYO 2024

At SusHi Tech Tokyo 2024, our CEO Jan Hendriks provided an insightful presentation on our patented MTC-Y transdermal drug delivery technology and showcases our main 2 projects – Transdermal Insulin and Transdermal Semaglutide. See Jan’s engaging presentation for yourself:

Read more

Media: Biotts Becomes First Company to Successfully Deliver Insulin Through Skin

Biotts, in collaboration with Bioton S.A., has achieved a historic milestone by successfully delivering insulin through a transdermal patch, eliminating the need for injections. Key highlights from the media coverage include: This innovation promises to improve patient comfort and care, making diabetes management more convenient and less invasive. The next phase aims to bring this […]

Read more

Transdermal Insulin Delivery: Progress from the Biotts-Bioton Partnership

At Biotts, our partnership with Bioton has been on an exciting journey towards revolutionizing transdermal insulin delivery. We are proud to share our key achievements so far and outline the path that lies ahead for this groundbreaking collaboration. Key Achievements Next Steps and Future Plans At Biotts, our partnership with Bioton remains committed to advancing […]

Read more